Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-91011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4702 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6875 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-48 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2002-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2006-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adc25484a4a060cc5469f40eb45ad948 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9200e8964290f09f192ccfd556a3ad0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6b1162770d8c30624cd054afe8551a5 |
publicationDate |
2006-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7052889-B2 |
titleOfInvention |
Mammalian SUV39H2 proteins and isolated DNA molecules encoding them |
abstract |
Murine and human Suv39h2 polypeptide and DNA molecules encoding them. Suv39h2 is a novel member of the Suv3-9 gene family. Suv39h2 is a novel component of meiotic higher order chromatin. It has histone methyltransferase activity and is required, in combination with Suv39h1, for male gametogenesis. Suv39h2 can be used in screening methods to identify modulators of its methyltransferase activity, which are useful in cancer therapy and for male contraception. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11633435-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10828356-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11180535-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10449237-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9616114-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9157114-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10729731-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11129906-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014094387-A1 |
priorityDate |
2000-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |